These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11531139)

  • 1. Prognostic significance of nuclear morphometry in superficial bladder cancer.
    Ozer E; Yörükoğlu K; Mungan MU; Ozkal S; Demirel D; Sağol O; Kirkali Z
    Anal Quant Cytol Histol; 2001 Aug; 23(4):251-6. PubMed ID: 11531139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of nuclear morphometry as predictive factor of progression in bladder papillary carcinoma].
    García I; Alvarez M; Hierro I; Vicioso L; Hidalgo R; Matilla A
    Actas Urol Esp; 1994; 18(10):937-41. PubMed ID: 7856480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms.
    Ramos D; Ruiz A; Morell L; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
    Anal Quant Cytol Histol; 2004 Oct; 26(5):285-94. PubMed ID: 15560535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of nuclear morphometry in renal cell carcinoma.
    Ozer E; Yörükoğlu K; Sagol O; Mungan U; Demirel D; Tüzel E; Kirkali Z
    BJU Int; 2002 Jul; 90(1):20-5. PubMed ID: 12081763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical prognostic factors in superficial cancer of the urinary bladder].
    Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
    Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas.
    Sagol O; Yörükoglu K; Tuna B; Ozer E; Sis B; Güray M; Mungan U; Kirkali Z
    Eur Urol; 2001 Aug; 40(2):163-8. PubMed ID: 11528193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
    Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma.
    Fukuzawa S; Hashimura T; Sasaki M; Yamabe H; Yoshida O
    Cancer; 1995 Nov; 76(10):1790-6. PubMed ID: 8625049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
    Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
    Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
    Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
    Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
    Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.